The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial.
暂无分享,去创建一个
Tonya S. King | E. Israel | H. Boushey | C. Sorkness | Richard J Martin | S. Peters | V. Chinchilli | S. Szefler | S. Lazarus | F. Leone | M. Kraft | M. Wechsler | J. Fahy | R. Lemanske | T. Craig | A. Deykin | T. King | E. DiMango | G. Pesola | L. Szwejbka
[1] Bradley E. Chipps. Daily Versus As-Needed Corticosteroids for Mild Persistent Asthma , 2006, Pediatrics.
[2] P. Paggiaro,et al. Low sputum eosinophils predict the lack of response to beclomethasone in symptomatic asthmatic patients. , 2006, Chest.
[3] C. Brightling. Sputum induction in asthma: a research technique or a clinical tool? , 2006, Chest.
[4] J. Cowan,et al. Exhaled nitric oxide: a predictor of steroid response. , 2005, American journal of respiratory and critical care medicine.
[5] J. Cowan,et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. , 2005, The New England journal of medicine.
[6] E. Israel,et al. Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. , 2005, The Journal of allergy and clinical immunology.
[7] G. Heldt,et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. , 2005, The Journal of allergy and clinical immunology.
[8] R. Pauwels,et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. , 2004, American journal of respiratory and critical care medicine.
[9] I. Pavord,et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.
[10] E. Israel,et al. Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial. , 2001, JAMA.
[11] E. Juniper,et al. Measuring asthma control in group studies: do we need airway calibre and rescue beta2-agonist use? , 2001, Respiratory medicine.
[12] K. J. Macleod,et al. Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma , 2000, Thorax.
[13] I. Pavord,et al. Non-eosinophilic cor ticosteroid unresponsive asthma , 1999, The Lancet.
[14] S. Szefler,et al. Time to onset of effect of fluticasone propionate in patients with asthma. , 1999, The Journal of allergy and clinical immunology.
[15] Lynn Wei,et al. Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic Asthma , 1999, Annals of Internal Medicine.
[16] W. Busse. Inflammation in asthma: the cornerstone of the disease and target of therapy. , 1998, The Journal of allergy and clinical immunology.
[17] W. Busse,et al. Efficacy and safety of inhaled corticosteroids. New developments. , 1998, American journal of respiratory and critical care medicine.
[18] Romain A. Pauwels. GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .
[19] E. Israel,et al. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network. , 1996, The New England journal of medicine.
[20] G. E. Noether,et al. Sample Size Determination for Some Common Nonparametric Tests , 1987 .
[21] H. Neijens,et al. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. , 1987, The Journal of allergy and clinical immunology.
[22] Stephen C Lazarus,et al. Banks CORTICOSTEROIDS FOR PERSISTENT ASTHMA SIGNIFICANT VARIABILITY IN RESPONSE TO INHALED Services , 2022 .